We are live on ! Find out more
VBIV

VBI Vaccines, Inc. New Common Stock (Canada)
VBIV

Delisted

VBIV was delisted on the 7th of August, 2024.

Back to rankings

17 hedge funds and large institutions have $26.8M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

21% more funds holding

Funds holding: 14 → 17 (+3)

11% more capital invested

Capital invested by funds: $24M → $26.8M (+$2.75M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
6
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$2.19M
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$683K
3
CV
Clarus Ventures
Massachusetts
+$445K
4
Citadel Advisors
Citadel Advisors
Florida
+$30.1K
5
Goldman Sachs
Goldman Sachs
New York
+$29.6K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$10K
2
Morgan Stanley
Morgan Stanley
New York
-$66

VBIV Hedge Fund Activity: Q1 2016 in Review

17 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q1 2016, worth a combined $26.8M — up 11% from $24M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new VBIV positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $2.19M. The largest seller was UBS Group, exiting entirely with an estimated $10K sold.

  • 17 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q1 2016, up from 14 in Q4 2015.
  • Funds reported $26.8M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q1 2016, up 11% quarter-over-quarter.
  • 4 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q1 2016 and 1 closed out, a net change of +3 holders.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q1 2016 was Hudson Bay Capital Management, an estimated $2.19M added.
  • The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q1 2016 was UBS Group, an estimated $10K sold.

Based on aggregated 13F filings for Q1 2016.